Genomics Company Twist Bioscience Partners with Pure Biologics
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a...
Tag : next generation sequencing technology
Genomics Co. Twist Bioscience Exercises Option to Purchase Software
Twist Bioscience (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it...
Precision BioSciences Onboards Stanley R. Frankel, M.D.
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, today announced...
Genomenon & Limbus Partner for Genomic Variant Interpretation
Genomenon® announced a partnership with Limbus Medical Technologies, which includes integration of the Mastermind® Genomic Search Engine into the cloud-based varvis® platform. In the initial integration available now, users of...
High-throughput Single-cell DNA Leader Names Yan Zhang as New CEO
Former Thermo Fisher Scientific exec to lead next phase of growing single-cell multi-omics company Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis,...
Population Genomics Leader Helix Partners with Ginkgo Bioworks
Together, Helix and Ginkgo will make easy, affordable, pooled COVID-19 testing accessible to teachers, staff, and students in these communities Helix, the leading population genomics...
Dante Labs Gets Certification for Genomic Interpretation Software
Dante Labs, a world leader in genomic sequencing and data analysis, announced today that it received ISO 13485:2016 certification for its Immensa Genomic Interpretation Software...
Inscripta Announces Shipment of Digital Genome Engineering Platform
GeneMill at the University of Liverpool receives first benchtop Onyx platform in Europe Financing round led by Fidelity and T. Rowe Price funds underscores vast...
PCR-based DNA manufacturor Applied DNA Onboards Clay Shorrock
– Shorrock Rejoins Company; Appointment Underscores Company’s Pursuit of Commercial Activities In Highly Regulated End-Markets, Including Biotherapeutics and Diagnostics – Applied DNA Sciences, Inc. (NASDAQ: APDN)...
Gene Therapy Company AavantiBio Onboards Dr. Christopher Wright
Neurologist and Neuroscientist with Deep Expertise in Orphan and CNS Drug Development Across Disease Areas AavantiBio, a gene therapy company focused on transforming the lives...